Form 4: CalciMedica Executive Eric W. Roberts Reports Stock Purchases

Eric W. Roberts, Chief Business Officer of CalciMedica, Inc., reports purchases of common stock through a Roth IRA.

Summary

• Eric W. Roberts, the Chief Business Officer of CalciMedica, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On April 1, 2024, Roberts purchased 746 shares of common stock at $3.90 per share through an Oppenheimer & Co Inc. Roth IRA.
• On April 2, 2024, Roberts purchased an additional 3,254 shares of common stock at $3.90 per share through the same Roth IRA.
• Following these transactions, Roberts indirectly owns 39,894 shares through the Oppenheimer Roth IRA.
• Roberts also indirectly owns shares through FMTC Custodian Roth IRA (5,223 shares), IRA Financial Trust Company (10,661 shares), Valence Investments SPV IV, LLC (356,989 shares), Valence Investments SPV V, LLC (66,228 shares), and Valence Investments SPV VI, LLC (316,109 shares).

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock purchases by an executive. It doesn't inherently convey positive or negative sentiment, but insider buying is generally viewed as a mildly positive signal.

Positives

• Executive's purchase of company stock may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track management's sentiment and alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view the executive's stock purchases as a positive sign.

Key Dates